K. Krause

OP0043 Twenty-Four Weeks of Treatment with a Novel Anti-IL-6 Receptor Nanobody® (ALX-0061) Resulted in 84% ACR20 Improvement and 58% DAS28 Remission in a Phase I/Ii Study in RA

B. Rojkovich, J. Holz, S. De Bruyn, 2013 .

Nursing diagnoses as guidelines in the care of the neonatal ECMO patient.

K. Krause, V. J. Youngner, 1992, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.